The main objective of the study is to assess the "FreeDom" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy will enable an early return home, patients using an innovative device that automatically adjusts and wean the oxygen flow (FreeO2 system) coupled to telemedicine and tele-rehabilitation.
The main hypothesis of this study is that a strategy for an early return home with a home hospitalization managed by telemedicine will reduce the length of hospitalization by 50 percent from 30 days.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All patients hospitalized for COPD exacerbation for less than 48 hours will be considered.
known or suspected COPD to entry
Age \> or = 40 years
Ex-smoker history (10 pack / year or more)
Acute Exacerbation: dyspnea of recent onset (less than 15 days)
The need for oxygen therapy with a moderate rate: \<6L / min to maintain SpO2 \> 90% (for oxygen dependent patient, the oxygen flow must be higher than flow at home)
You may not be if
Refusal to consent to participate in the study,
Indication for an imminent intubation according to the pulmonologist,
Sleep Apnea
NIV used at home
Lack of FreeO2 system available at the time of randomization
Non-autonomous and alone at home
Patient alone at home
Patients who live more than 50 km from the hospital
Patient already included in the study within 3 months
Clareo Health | FreeDom: Innovative Strategy for the Management of COPD Exacerbations
